Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Solid Biosciences (SLDB) Receivables - Other (2020 - 2022)

Solid Biosciences' Receivables - Other history spans 3 years, with the latest figure at $14000.0 for Q1 2022.

  • For Q1 2022, Receivables - Other fell 95.0% year-over-year to $14000.0; the TTM value through Mar 2022 reached $14000.0, down 95.0%, while the annual FY2021 figure was $110000.0, N/A changed from the prior year.
  • Receivables - Other for Q1 2022 was $14000.0 at Solid Biosciences, down from $110000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $594000.0 in Q3 2021 and bottomed at $14000.0 in Q1 2022.
  • The 3-year median for Receivables - Other is $283000.0 (2020), against an average of $261666.7.
  • The largest annual shift saw Receivables - Other changed 0.0% in 2021 before it crashed 95.0% in 2022.
  • A 3-year view of Receivables - Other shows it stood at $286000.0 in 2020, then crashed by 61.54% to $110000.0 in 2021, then plummeted by 87.27% to $14000.0 in 2022.
  • Per Business Quant, the three most recent readings for SLDB's Receivables - Other are $14000.0 (Q1 2022), $110000.0 (Q4 2021), and $594000.0 (Q3 2021).